Molecular Oncology
A section of International Journal of Molecular Sciences (ISSN 1422-0067).
Section Information
This section of the International Journal of Molecular Sciences (IJMS) aims to rapidly publish contributions on all aspects of the most recent research on human cancers. This section lies at the interface between medicinal chemistry and oncology research. We encourage the submission of high-quality manuscripts that provide novel mechanistic insights and details of the molecular signatures of oncogenic transformation. The scope of this section includes, but is not limited to, the following:
- Biological processes like gene activity and metabolisms in the development and progression of cancers
- Mechanisms of metastasis (vascular and lymphatic dissemination and seeding)
- Molecular pathology and immunology in tumor development
- Biomarkers in diagnostic processes
- Novel therapies like drug therapy, radiotherapy, gene therapy, hormonal therapy, and immunotherapy
- Cancer vaccines
Editorial Board
Topic Board
Special Issues
Following special issues within this section are currently open for submissions:
- Characterizing Colorectal Cancer: MicroRNAs Are Key Molecules Involved in the Gene Regulation Network of Carcinogenesis (Deadline: 25 September 2021)
- MicroRNAs and Long Noncoding RNAs in Tumor Microenvironment (Deadline: 30 September 2021)
- Glioblastoma: Recapitulating the Key Breakthroughs and Future Perspective (Deadline: 30 September 2021)
- New Molecular Targets in Lung Cancer (Deadline: 30 September 2021)
- Aberrations of DNA Repair Pathways in Prostate Cancer (Deadline: 30 September 2021)
- Solitary Fibrous Tumors: Diagnosis, Classification and Therapy (Deadline: 30 September 2021)
- New Strategies in Therapeutic Targets of Soft Tissue Sarcoma: Translational Implications (Deadline: 30 September 2021)
- Telomeres, Telomerase and Cancer (Deadline: 30 September 2021)
- Role of Lipids in Cancer (Deadline: 30 September 2021)
- Molecular Pathology of Triple-Negative Breast Cancer and Therapeutic Implications (Deadline: 30 September 2021)
- Lipid as a Cancer Therapeutic Target 2.0 (Deadline: 30 September 2021)
- Frontiers Research in Brain Tumors: Molecular, Histopathological and Imaging Insights (Deadline: 30 September 2021)
- Study on “Stemness” of Cancer Cells and Main Cause of Cancer Relapse after Standard Therapy (Deadline: 30 September 2021)
- Transcriptional Mechanism of Glycosyltransferase Genes Related to Cancer and Diseases (Deadline: 30 September 2021)
- Secretome and Its Maturation in Tumor Microenvironment and Metastasis (Deadline: 30 September 2021)
- PSMA in Prostate Cancer (Deadline: 30 September 2021)
- Integrin Signalling in Cancer (Deadline: 30 September 2021)
- The Research about Microbiome and Cancer (Deadline: 30 September 2021)
- Contribution of Cancer-Targeting Drugs toward Faster Clinical Application (Deadline: 30 September 2021)
- Macrophages in the Glioblastoma Tumor Microenvironment (Deadline: 15 October 2021)
- The Research of Neutrophil (Deadline: 29 October 2021)
- Enzyme Inhibitors and Activators in Cancer Research, Therapy and Prevention (Deadline: 30 October 2021)
- Gliomas: From Molecular Mechanisms to Therapeutic Approaches (Deadline: 31 October 2021)
- Molecular Interactions between Cancer Cells and Tumor Microenvironment 2.0 (Deadline: 31 October 2021)
- Molecular Drivers of Responsiveness to Cancer Immunotherapy (Deadline: 31 October 2021)
- Tumor Secretome in Translational Oncology (Deadline: 31 October 2021)
- Peptides and Their Conjugates for Cancer Therapy (Deadline: 31 October 2021)
- RNA Dysregulation in Human Diseases: from Basic to Translational Applications (Deadline: 31 October 2021)
- Cytokines/Chemokines in Cancer Metastasis 2.0 (Deadline: 31 October 2021)
- Tumor Microenvironment in Colorectal Cancer (Deadline: 31 October 2021)
- Viruses and Cancers (Deadline: 31 October 2021)
- Advances in Molecular Genetics of Brain Tumors (Deadline: 31 October 2021)
- TGF-Beta Signaling in Glioblastoma (Deadline: 31 October 2021)
- Gynaecological Tumours and Sarcomas (Deadline: 31 October 2021)
- Precision Medicine, Pharmacogenomics and Cancer Treatment (Deadline: 31 October 2021)
- Pancreatic Fibrosis in Inflammation and Cancer (Deadline: 31 October 2021)
- Ephrin Receptors and Cancer (Deadline: 31 October 2021)
- Non-coding RNAs in Glioblastoma Multiforme (Deadline: 31 October 2021)
- Theme Issue Honoring Prof. Dr. Ludger Wessjohann’s 60th Birthday: Natural Products in Modern Drug Discovery (Deadline: 31 October 2021)
- Skin Cancer: State-of-the-Art (Deadline: 31 October 2021)
- Liver Cancer (Deadline: 31 October 2021)
- Altered RNA Processing in Tumor Pathogenesis and Therapy (Deadline: 31 October 2021)
- DNA Damage, DNA Repair, and Cancer (Deadline: 31 October 2021)
- Preclinical Cancer Therapeutics of Precision Medicine (Deadline: 15 November 2021)
- Multiple Myeloma: Focus on Molecular and Epigenetic Aspects (Deadline: 20 November 2021)
- The Role of DNA Damage and Repair in Cancer (Deadline: 26 November 2021)
- Gene and Cell-Based Cancer Therapies (Deadline: 29 November 2021)
- Gastrointestinal Cancers: Molecular Pathophysiology, Novel Biomarkers and Therapeutic Approaches (Deadline: 30 November 2021)
- Mitochondrial Metabolism in Cancer (Deadline: 30 November 2021)
- Biomarkers for Diagnosis and Prognosis in Urological Tumors II (Deadline: 30 November 2021)
- Clarification of Mechanism of Carcinogenesis (Deadline: 30 November 2021)
- Breast Cancer: From Pathophysiology to Novel Therapeutic Approaches 2.0 (Deadline: 30 November 2021)
- Lipid Metabolism in Cancer as a Source of Biomarkers and Therapeutical Targets (Deadline: 30 November 2021)
- Pharmacogenomic and Pharmacogenetic Characterisation of Sarcomas (Deadline: 30 November 2021)
- DNA Repair in Cancers 2.0 (Deadline: 30 November 2021)
- Novel Players in Chemioresistance as New Targets for Cancer Treatment (Deadline: 30 November 2021)
- Chemotherapeutic Agents in Gynecological Cancers: Drug Design, Development and Therapy (Deadline: 30 November 2021)
- New Insights into the Pathophysiology of Gynecological Cancers (Deadline: 30 November 2021)
- Proteases: Role and Function in Cancer (Deadline: 30 November 2021)
- Plant-Based Cancer Drug Discovery: Natural Products with Anti-Cancer Activity (Deadline: 30 November 2021)
- Cancer Metastatic Cascade: Plasticity of EMT and Stem Programs (Deadline: 30 November 2021)
- Signal Transduction Pathways Involved in Regulation of Normal and Tumour Cells (Deadline: 30 November 2021)
- Signaling in Melanoma 2.0 (Deadline: 30 November 2021)
- Novel Insights into Soft Tissue Sarcoma (Deadline: 30 November 2021)
- Endometrial Cancer in Reproductive Age: Fertility-Sparing Approach and Obstetric Outcomes (Deadline: 30 November 2021)
- Novel Therapeutic Treatments to Target Glioblastoma Intratumoral Heterogeneity and Plasticity (Deadline: 1 December 2021)
- Cancers across Phylogeny and Cancer Evolution (Deadline: 15 December 2021)
- Noncoding RNAs as New Instruments in the Orchestration of Cell Death and Cancer Therapy Resistance 2.0 (Deadline: 15 December 2021)
- Therapy-Promoted Cancer Repopulation and Acquired Cell-Resistance: Beyond Gene Mutation (Deadline: 15 December 2021)
- Advances in the Molecular Basis of BRCA-Associated Cancers (Deadline: 22 December 2021)
- New Strategies to Overcome Resistance to Chemotherapy and Immune System in Cancer 3.0 (Deadline: 31 December 2021)
- Inflammation and Gastrointestinal Cancers: Molecular Mechanisms and Therapies 2.0 (Deadline: 31 December 2021)
- Transcriptional and Post-Transcriptional Dysregulation and Cancer Driver Pathways 2.0 (Deadline: 31 December 2021)
- The Promise of Precision Oncology in Breast Cancer (Deadline: 31 December 2021)
- Oral Fibrosis and Oral Cancer: From Molecular Targets to Therapeutics 2.0 (Deadline: 31 December 2021)
- Epigenetic Regulation of Stem Cells and Cancer (Deadline: 31 December 2021)
- Molecular Mechanism of Anti-inflammatory Actions of Natural Components (Deadline: 31 December 2021)
- Dichloroacetate (DCA) and Cancer: Advancing DCA to a Cancer Therapeutic (Deadline: 31 December 2021)
- Molecular Signal Transduction in Tumor Progression and Metastasis (Deadline: 31 December 2021)
- Cancer Stem Cells in Basic Science and in Translational Oncology (Deadline: 31 December 2021)
- Novel Agents and Mechanisms in Acute Leukemias (Deadline: 31 December 2021)
- The Epithelial-to-Mesenchymal Transition (EMT) in Cancers (Deadline: 31 December 2021)
- Molecular Alterations in GastroIntestinal Pre-invasive Lesions (Deadline: 31 December 2021)
- Advances in Cancer Stem Cells (Deadline: 31 December 2021)
- Epigenetic and Transcriptional Networks in Soft Tissue Sarcomas (Deadline: 31 December 2021)
- Role of HIF-1 in Cancer Metabolism and Progression (Deadline: 31 December 2021)
- Deciphering the Therapeutic Resistance of Hematologic Malignancies (Deadline: 31 December 2021)
- Cancer: Novel Approaches in the Discovery and Design of Targeted Therapies (Deadline: 31 December 2021)
- Hematopoietic Stem Cells, Metabolic Regulations, and Aging (Deadline: 31 December 2021)
- Circulating Tumor Cells: Pathological, Molecular and Functional Characteristics 3.0 (Deadline: 31 December 2021)
- Melatonin and Vitamin D: Molecular Mechanisms and Biological Function (Deadline: 31 December 2021)
- Autophagy in Cancer Progression and Therapeutics (Deadline: 31 December 2021)
- Sarcoma (Deadline: 31 December 2021)
- Recent Advances in Thyroid Cancer Research (Deadline: 31 December 2021)
- Bioactive Phytochemicals for Cancer Prevention and Treatment 3.0 (Deadline: 31 December 2021)
- Advances in Immuno-Oncology (Deadline: 31 December 2021)
- Frontiers in Molecular Biology of Brain Tumors (Deadline: 31 December 2021)
- MicroRNA as Biomarkers in Cancer Diagnostics and Therapeutics (III) (Deadline: 31 January 2022)
- Hormones-Dependent Cancers: New Aspects on Biochemistry and Molecular Pathology 4.0 (Deadline: 31 January 2022)
- In Vivo Biomarkers for Immunotherapy Efficacy in Brain Tumours (Deadline: 31 January 2022)
- Molecular Pathology of Bone and Soft Tissue Tumors (BSTT) (Deadline: 31 January 2022)
- Primary Intraocular Tumors–Molecular Mechanisms, Novel Therapeutic Strategies and Targets (Deadline: 31 January 2022)
- Causalities and Regulations of Tumor Metastasis 2.0 (Deadline: 31 January 2022)
- Molecular Mechanisms of Tumor Suppressor Genes (Deadline: 31 January 2022)
- Implication of Nanoparticles in Cancer Therapy Research (Deadline: 31 January 2022)
- Mitochondrial Plasticity in Cancer (Deadline: 31 January 2022)
- Poor-Risk and Relapsed/Refractory Germ Cell Tumor (Deadline: 31 January 2022)
- Mechanism of Cell Proliferation in Glioblastoma and Melanoma (Deadline: 31 January 2022)
- Nutrition and Cancer: Recent Advances and Future Perspectives (Deadline: 31 January 2022)
- Emerging Role of Immunotherapies in Cancer and Their Cardiotoxic Effects (Deadline: 31 January 2022)
- Molecular Characteristics of Renal Cell Carcinoma (Deadline: 31 January 2022)
- Advances in Cancer Metabolism and Tumour Microenvironment 2.0 (Deadline: 31 January 2022)
- Cancer and Neurodegenerative Diseases: What Is the Link? (Deadline: 31 January 2022)
- NK Cells, Immune Response in Pathology and Cancer (Deadline: 31 January 2022)
- Molecular Mechanisms and Therapies of Hepatocellular Carcinoma (Deadline: 31 January 2022)
- Tumor-Host Interactions (Deadline: 31 January 2022)
- Natural Bioactives and Phytochemicals in Cancer Prevention 2.0 (Deadline: 31 January 2022)
- Molecular Advances in Cancer Therapy (Deadline: 28 February 2022)
- Targeting Myeloid-Derived Suppressor Cells in Breast Cancer (Deadline: 28 February 2022)
- Oncogenic Signaling of Growth Factor Receptors in Cancer 2.0: Mechanisms and Therapeutic Opportunities (Deadline: 28 February 2022)
- DNA Methylation in Cancer Development and Progression (Deadline: 28 February 2022)
- New Insights into Endometrial Cancer 2021 (Deadline: 28 February 2022)
- Skin Cancer and Melanoma (Deadline: 28 February 2022)
- Cancer Cell Metabolism 2.0 (Deadline: 28 February 2022)
- Mitochondria and Cancer: The Giant Screen View (Deadline: 28 February 2022)
- Cancer Immunotherapy: Recent Advances and Prospects (Deadline: 28 February 2022)
- Liquid Biopsies in Oncology (Deadline: 28 February 2022)
- Recent Advances in Neuroendocrine Neoplasms Research (Deadline: 28 February 2022)
- Advances in Genome Regulation in Cancer (Deadline: 31 March 2022)
- Circulating Cell-Free Nucleic Acids and Cancers (Deadline: 31 March 2022)
- The Bidirectional Relationship between Cancer Epigenetics and Metabolism (Deadline: 31 March 2022)
- Molecular Diagnostics, Pathology and Biomarkers of Gastrointestinal Neoplasms (Deadline: 31 March 2022)
- Novel Insights into Molecular Biology of Urological Cancers (Deadline: 31 March 2022)
- Endometrial Cancer Overview: Molecular Biology and Its Potential Clinical Application (Deadline: 31 March 2022)
- Molecular Biology of Melanoma 2.0 (Deadline: 31 March 2022)
- Current Use and Perspectives of Molecular Assessment in Breast Cancer (Deadline: 15 April 2022)
- Alternative Splicing in Cancer: Role, Mechanisms and Impact (Deadline: 30 April 2022)
- Pleiotropic Effect of β-Adrenergic Receptors in Human Cancers and Other Human Diseases II (Deadline: 31 May 2022)
- Cancer Immunoediting and Beyond 2021 (Deadline: 31 May 2022)
- Pancreatic Ductal Adenocarcinoma: Precursors and Variants 2.0 (Deadline: 31 May 2022)
- Malignant Melanoma: Molecular Mechanism and New Agents for Prevention and Therapy (Deadline: 30 June 2022)
Topical Collections
Following topical collections within this section are currently open for submissions:
